For an extensive iliofemoral DVT in a young patient, blood thinners alone are not enough. CDT dissolves the clot, restores venous function, and prevents decades of swelling and disability.
Written by Dr Rahul Agarwal, Consultant Vascular & Endovascular Surgeon
CARE Hospitals, Banjara Hills, Hyderabad
For most DVT patients, anticoagulation (blood thinners) is the appropriate treatment. But for some patients — particularly young people with large, acute clots in the major veins of the thigh or pelvis — catheter-directed thrombolysis (CDT) offers a significantly better outcome by actively dissolving the clot rather than just preventing it from growing.
🦠 What Is CDT?
Catheter-directed thrombolysis is a minimally invasive procedure where a catheter is inserted (usually via the popliteal vein behind the knee) and threaded directly into the clot. Clot-dissolving drugs (thrombolytics such as alteplase or urokinase) are then infused directly into the clot over 24–48 hours in a vascular ICU or high-dependency unit. This achieves far higher local drug concentrations — with far less systemic bleeding risk — than IV thrombolysis.
🏥 Who Benefits from CDT?
- Young patients (<60 years) with acute (less than 14 days old) iliofemoral DVT
- Patients with phlegmasia cerulae dolens — severe DVT threatening limb viability
- Patients where preserving venous valve function matters long-term
- Patients with good cardiorespiratory reserve and no contraindication to thrombolytics
📊 The Goal: Preventing Post-Thrombotic Syndrome
Post-thrombotic syndrome (PTS) affects 30–50% of DVT patients despite anticoagulation. It causes chronic leg swelling, pain, skin discolouration, and eventually venous ulcers. CDT reduces the clot burden more effectively than anticoagulation alone, preserves venous valve function, and significantly reduces PTS risk in suitable patients.
❓ FAQ
Is CDT safe?
CDT carries a risk of bleeding — the thrombolytic drug can cause bleeding at any site. Serious bleeding (including intracranial) occurs in approximately 1–2% of cases. Patients are monitored continuously in a vascular HDU during the infusion. The risk-benefit must be carefully assessed for each individual.
How long does CDT take?
The thrombolytic infusion typically runs for 24–48 hours. Progress is checked by venogram (X-ray imaging of the vein) every 12–24 hours. After clot dissolution, underlying venous stenosis may be treated with balloon angioplasty and stenting in the same session.
💡 Key Insight: CDT is not for every DVT patient — but for a young patient with an extensive iliofemoral DVT, it is the difference between good venous function for life and three decades of swelling, ulcers, and disability. The window is narrow: CDT works best within 7–14 days of clot formation.
📖 Related: DVT & Pulmonary Embolism | Endovascular Procedures | What Does a Vascular Surgeon Do?
About the Author 🧑🏻⚕️
Dr Rahul Agarwal is a Consultant Vascular & Endovascular Surgeon at CARE Hospitals, Banjara Hills, Hyderabad.